T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Revenue Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual revenue in 2023 was 7.19 Million USD , down -67.75% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly revenue in 2024 Q1 was 2.06 Million USD , up 22.75% from previous quarter.
  • T2 Biosystems, Inc. reported a annual revenue of 22.3 Million USD in annual revenue 2022, down -20.5% from previous year.
  • T2 Biosystems, Inc. reported a annual revenue of 28.05 Million USD in annual revenue 2021, up 54.76% from previous year.
  • T2 Biosystems, Inc. reported a quarterly revenue of 1.95 Million USD for 2024 Q2, down -5.29% from previous quarter.
  • T2 Biosystems, Inc. reported a quarterly revenue of 2.07 Million USD for 2023 Q1, down -62.1% from previous quarter.

Annual Revenue Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Revenue of T2 Biosystems, Inc. (2023 - 2012)

Year Revenue Revenue Growth
2023 7.19 Million USD -67.75%
2022 22.3 Million USD -20.5%
2021 28.05 Million USD 54.76%
2020 18.13 Million USD 117.52%
2019 8.33 Million USD -20.62%
2018 10.5 Million USD 125.03%
2017 4.66 Million USD 14.36%
2016 4.08 Million USD 45.04%
2015 2.81 Million USD 2263.87%
2014 119 Thousand USD -55.26%
2013 266 Thousand USD 1300.0%
2012 19 Thousand USD 0.0%

Peer Revenue Comparison of T2 Biosystems, Inc.

Name Revenue Revenue Difference
Bionano Genomics, Inc. 36.11 Million USD 80.084%
Prenetics Global Limited 21.74 Million USD 66.918%
Star Equity Holdings, Inc. 45.78 Million USD 84.29%
CareDx, Inc 280.32 Million USD 97.434%
Exact Sciences Corporation 2.49 Billion USD 99.712%
Exagen Inc. 52.54 Million USD 86.312%
Inotiv, Inc. 572.42 Million USD 98.743%
Guardant Health, Inc. 563.94 Million USD 98.725%
Biodesix, Inc. 49.08 Million USD 85.346%
BioNexus Gene Lab Corp. 9.77 Million USD 26.383%
Precipio, Inc. 15.19 Million USD 52.668%
iSpecimen Inc. 9.92 Million USD 27.55%
Natera, Inc. 1.08 Billion USD 99.336%
Aspira Women's Health Inc. 9.15 Million USD 21.422%
Standard BioTools Inc. 106.34 Million USD 93.236%
23andMe Holding Co. 219.63 Million USD 96.725%
Castle Biosciences, Inc. 219.78 Million USD 96.727%
Personalis, Inc. 73.48 Million USD 90.211%
Aclaris Therapeutics, Inc. 31.24 Million USD 76.982%
Applied DNA Sciences, Inc. 13.36 Million USD 46.19%
OpGen, Inc. 3.41 Million USD -110.425%
Myriad Genetics, Inc. 678.4 Million USD 98.94%
ICON Public Limited Company 8.12 Billion USD 99.911%
NeoGenomics, Inc. 591.64 Million USD 98.784%
Star Equity Holdings, Inc. 45.78 Million USD 84.29%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.804%
RadNet, Inc. 1.61 Billion USD 99.555%
MDxHealth SA 70.19 Million USD 89.753%
Psychemedics Corporation 22.09 Million USD 67.45%
Illumina, Inc. 4.5 Billion USD 99.84%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 97.702%
DarioHealth Corp. 20.35 Million USD 64.657%
Fulgent Genetics, Inc. 289.21 Million USD 97.513%
Sera Prognostics, Inc. 306 Thousand USD -2250.654%
ENDRA Life Sciences Inc. - USD -Infinity%
OPKO Health, Inc. 863.49 Million USD 99.167%
Medpace Holdings, Inc. 1.88 Billion USD 99.619%
Neogen Corporation 924.22 Million USD 99.222%
Intelligent Bio Solutions Inc. 3.11 Million USD -131.154%
Prenetics Global Limited 21.74 Million USD 66.918%
Mainz Biomed B.V. 895.47 Thousand USD -703.257%
bioAffinity Technologies, Inc. 2.53 Million USD -184.028%
Trinity Biotech plc 56.83 Million USD 87.343%
Neuronetics, Inc. 71.34 Million USD 89.918%
Sotera Health Company 1.04 Billion USD 99.314%
bioAffinity Technologies, Inc. 2.53 Million USD -184.028%